Alintegimod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alintegimod, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy [Phase 1, Phase 2]